About Shannon Blalock

Dr. Shannon Blalock is Chief Executive Officer and a Board Member at jCyte. He brings more than 25 years of commercialization and operational expertise within the pharmaceutical industry. Dr. Blalock joined jCyte, from Santen Pharmaceuticals, where he served as the Global Leader for Portfolio Development & Global R&D Strategy. Prior to Santen, he co-founded and was the Chief Commercial Officer of AltheaDx after working at GlaxoSmithKline (GSK) for more than a decade where he led both US and International businesses of increasing size and scope. Dr. Blalock earned his undergraduate and Doctor of Pharmacy degrees from the University of North Carolina at Chapel Hill.